Arsalan Arif is a news media entrepreneur who set out in 2015 to build his vision of an independent biotech news company at Endpoints News. The former publisher of FierceMarkets’ life sciences division, he grew FierceBiotech from a small email news aggregator into a reliably profitable multimillion-dollar franchise, with a global team of editors and sales executives. Now he’s bringing some fresh ideas tempered with old-school know-how to work at Endpoints. Arsalan’s primary responsibilities at Endpoints are finance, talent recruitment, and technology development — in that order. His journalism duties include daily stewardship of the Early Edition email and covering the biopharma cybersecurity beat. The son of immigrant entrepreneurs, he received his business education by watching his parents run brick-and-mortar stores in Kansas. Arsalan was born and raised in the aviation capital of the world, Wichita, and has been a private pilot for 19 years. After spending most of his adult life in Washington, DC, he recently moved to Lawrence, Kansas, with his family.
What if patients were not patients anymore? For companies developing gene therapies for rare…